Patient preferences and quality of life associated with colorectal cancer screening

American Journal of Gastroenterology

Volumn 92, Issue 12 SUPPL., 1997, Pages 2171-2178

  Dominitz, Jason A ^a   Provenzale, Dawn ^b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COLOSTOMY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; SIGMOIDOSCOPY;

AGED; ATTITUDE TO HEALTH; COLONIC NEOPLASMS; COLONOSCOPY; COLOSTOMY; DECISION MAKING; FEMALE; HEALTH STATUS; HUMANS; INTERVIEWS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; QUALITY OF LIFE; RECTAL NEOPLASMS; SIGMOIDOSCOPY;

EID: 0030832906     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Nease RF Jr, Kneeland T, O'Connor GT, et al. Variation in patient utilities for outcomes of the management of chronic stable angina: Implications for clinical practice guidelines. JAMA 1995;273:1185-90.
2. Eddy D. Connecting value and costs: Whom do we ask, and what do we ask them? JAMA 1990;264:1737-9.
3. Grady D, Cummings SR, Petitti DB, et al. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992;117:1038-41.
4. Owens DK, Nease RF Jr. Development of outcomes-based practice guidelines: A method for structuring problems and synthesizing evidence. Jt Comm J Qual Improv 1993;19:248-63.
5. ACC/AHA guidelines and indications for coronary bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee on coronary artery bypass graft surgery). Circulation 1991;83:1125-73.
6. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation 1990;82:1629-46.
7. Lieberman DL. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995;109:1781-90.
8. Hart AR, Wicks AC, Mayberry JF. Colorectal cancer screening in asymptomatic populations. Gut 1995;36:590-8.
9. Van Dam J, Bond JH, Sivak MV. Fecal occult blood screening for colorectal cancer. Arch Intern Med 1995;155:2389-402.
10. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972;7:118-33.
11. Churchill DN, Torrance GW, Taylor WD, et al. Measurement of , quality of life in end-stage renal disease: The time trade off approach. Clin Invest Med 1987;10:14-20.
12. McLeod RS, Churchill DN, Lock AM, et al. Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology 1991;101:1307-13.
13. McLeod RS, Taylor BR, O'Connor BI, et al. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 1995;169:179-85.
14. Stiggelbout AM, Kiebert GM, Kievit J, et al. The "utility" of the time trade-off method in cancer patients: Feasibility and proportional tradeoff. J Clin Epidemiol 1995;48:1207-14.
15. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;433-41.
16. Siegel S, Castellan NJ Jr. Nonparametric statistics for the behavioral sciences, 2nd ed. New York: McGraw-Hill, 1988.
17. Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
18. Peterson BL, Harrell FE. Partial proportional odds model for ordinal response variables. Appl Statist 1990;39:205-17.
19. Weller DP, Owen N, Hiller JE, et al. Colorectal cancer and its prevention: Prevalence of beliefs, attitudes, intentions and behaviour. Aust J Public Health 1995;19:19-23.
20. Kelly RB, Shank JC. Adherence to screening flexible sigmoidoscopy in asymptomatic patients. Med Care 1992;30:1029-42.
21. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. Gastrointest Endosc 1996;43:309 (abstract).
22. Elwood JM, Ali G, Schlup MM, et al. Flexible sigmoidoscopy or colonoscopy for colorectal screening: A randomized trial of performance and acceptability. Cancer Detect Prev 1995;19:337-47.
23. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: A basic science for clinical medicine. Boston: Little, Brown, 1991.
24. Lillard LA, Manning WG, Peterson CE, et al. Preventive medical care: Standards, usage and efficiency, publication JR-3266-HC-FA. Santa Monica, CA: RAND, 1986.
25. Notar-Francesco VJ, Zakai MD, Raufman JP. Gastroenterologists' attitudes and practices regarding colon cancer screening: Do we practice what we preach? Gastroenterology 1995;108:A27.
26. McCarthy BD, Moskowitz MA. Screening flexible sigmoidoscopy: Patient attitudes and compliance. J Gen Intern Med 1993;8:120-5.
27. Drossman DA, Brandt LJ, Sears C, et al. A preliminary study of patients' concerns related to GI endoscopy. Am J Gastroenterol 1996; 91:287-91.
28. Thomas W, White CM, Mah J, et al. Longitudinal compliance with annual screening for fecal occult blood. Am J Epidemiol 1995;142: 176-82.
29. Hardcastle JD, Thomas WM, Chamberlain J, et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer: Results for the first 107,349 subjects. Lancet 1989;1:1160-4.
30. Winawer SJ, Flehinger BJ, Schottenfeld D, et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993;85:1311-8.
31. Lindholm E, Berglund B, Haglind E, et al. Factors associated with participation in screening for colorectal cancer with faecal occult blood testing. Scand J Gastroenterol 1995;30:171-6.
32. Robinson MHE, Kronborg O, Williams CB, et al. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia. Br J Surg 1995;82:318-20.
33. Sandier RS, Devellis BM, Blalock SJ, et al. Participation of high-risk subjects in colon cancer screening. Cancer 1989;63:2211-5.
34. Kronborg O, Fenger C, Worm J, et al. Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1992;27:47-52.
35. Elwood TW, Erickson A, Lieberman S. Comparative educational approaches to screening for colorectal cancer. Am J Public Health 1978; 68:135-8.
36. Winchester DP, Shull JH, Scanlon EF, et al. A mass screening program for colorectal cancer using chemical testing for occult blood in stool. Cancer 1980;45:2955-8.
37. Mant D, Chivers A, Fuller A, et al. Patient compliance with colorectal cancer screening in general practice. Br J Gen Pract 1992;42:18-20.
38. Nichols S, Koch E, Lallemand RC, et al. Randomised trial of compliance with screening for colorectal cancer. BMJ 1986;293:107-10.
39. Myers RE, Ross EA, Wolf TA, et al. Behavioral interventions to increase adherence in colorectal cancer screening. Med Care 1991;29: 1039-50.
40. Woodman CBJ, Prior P, Watson A. Prospects for the secondary prevention of colorectal cancer: Screening by flexible sigmoidoscopy? J Med Screen 1995;2:71-8.
41. Foley DP, Dunne P, O'Brien M, et al. Left sided colonoscopy as screening procedure for colorectal neoplasia in asymptomatic volunteers ≥ 45. Gut 1987;28:A1367.
42. Hoff G, Vatn M, Gjone E, et al. Epidemiology of polyps in the rectum and sigmoid colon: Design of a population screening study. Scand J Gastroenterol 1985;20:351-5.
43. Cockburn J, Thomas RJ, McLaughlin SJ, et al. Acceptance of screening for colorectal cancer by flexible sigmoidoscopy. J Med Screen 1995;2:79-83.
44. Stephenson BM, Murday VA, Finan PJ, et al. Feasibility of family based screening for colorectal neoplasia: Experience in one general surgical practice. Gut 1993;34:96-100.
45. Hynam KA, Hart AR, Gay SP, et al. Screening for colorectal cancer: Reasons for refusal of faecal occult blood testing in a general practice in England. J Epidemiol Community Health 1995;49:84-6.
46. Myers RE, Ross E, Jepson C, et al. Modeling adherence to colorectal cancer screening. Prev Med 1994;23:142-51.
47. Jepson C, Kessler LG, Portnoy B, et al. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health 1991; 81:501-4.
48. Cooper GS, Yuan Z, Landefeld S, et al. Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health 1996;86:582-6.
49. Dolan NC, Reifler DR, McGrae McDermott M, et al. Adherence to screening mammography recommendations in a university general medicine clinic. J Gen Intern Med 1995;10:299-306.
50. Margolis KL, Lurie N, McGovern PG, et al. Predictors of failure to attend scheduled mammography appointments at a public teaching hospital. J Gen Intern Med 1993;8:602-5.
51. Martin LM, Calle EE, Wingo PA, et al. Comparison of mammography and Pap test use from the 1987 and 1992 National Health Interview Surveys: Are we closing the gaps? Am J Prevent Med 1996;12:82-90.
52. Roetzheim RG, Fox SA, Leake B. Physician-reported determinants of screening mammography in older women: The impact of physician and practice characteristics. J Am Geriatr Soc 1995;43:1398-402.
53. Provenzale D, Shearin M, Phillips-Bute B, et al. Health related quality of life after ileoanal pull-through: Evaluation and assessment of new health status measures. Gastroenterology 1997;113:7-14.
54. Matchar DB, McCrory DC, Bennett CL. Treatment considerations for persons with metastatic prostate cancer: Survival versus out-of-pocket costs. Urology 1997;49:218-24.
55. Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990;113: 373-84.